Pipeline栓塞装置治疗复杂颈内动脉瘤的长期临床与血管造影结局:Pipeline for Uncoilable or Failed Aneurysms试验五年结果
该前瞻性多中心 trial 纳入107例受试者的109个复杂颈内动脉瘤,采用Pipeline栓塞装置治疗并按标准化方案随访至5年。动脉瘤完全闭塞率随时间由180天的73.6%升至1年的86.8%、3年的93.4%和5年的95.2%,5年随访中96.3%的患者改良Rankin量表评分≤2。作者认为PED治疗颅内颈内动脉大型及巨大型宽颈动脉瘤安全有效,完全闭塞率高且迟发不良事件率低。
要点
- 5年随访时动脉瘤完全闭塞率达95.2%(60/63),且未见已闭塞动脉瘤再通。
- 1、3、5年新发严重器械相关事件率分别为1%(1/96)、3.5%(3/85)和0%(0/81)。
- 81例有5年临床随访的患者中78例(96.3%)改良Rankin量表评分≤2。
核心结论
- 5年结果提示Pipeline栓塞装置治疗颅内颈内动脉大型和巨大型宽颈动脉瘤安全有效,完全闭塞率高且迟发不良事件率低。
研究设计与样本
- 前瞻性多中心 trial(Pipeline for Uncoilable or Failed Aneurysms),共107例受试者的109个复杂颈内动脉瘤接受Pipeline栓塞装置治疗,按标准化方案在180天及1、3、5年随访。
主要发现
- 180天完全闭塞率73.6%为既往已报告的主要终点。
- 有血管造影随访者的动脉瘤完全闭塞率随时间逐步升高,1年为86.8%(79/91)、3年为93.4%(71/76)、5年为95.2%(60/63)。
- 6个动脉瘤(5.7%)接受再治疗。
- 1、3、5年新发严重器械相关事件分别见于1%(1/96)、3.5%(3/85)和0%(0/81)的受试者。
- trial 中报告4例(3.7%)死亡;81例有5年临床随访的患者中78例(96.3%)改良Rankin量表评分≤2。
关键数值与推荐
- 6个月以后未报告迟发性神经源性死亡或出血性、缺血性脑血管事件。
- 未观察到既往已闭塞动脉瘤再通。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early and mid-term safety and efficacy of aneurysm treatment with the Pipeline Embolization Device (PED) has been well demonstrated in prior studies. OBJECTIVE: To present 5-yr follow-up for patients treated in the Pipeline for Uncoilable or Failed Aneurysms clinical trial. METHODS: In our prospective, multicenter trial, 109 complex internal carotid artery (ICA) aneurysms in 107 subjects were treated with the PED. Patients were followed per a standardized protocol at 180 d and 1, 3, and 5 yr. Aneurysm occlusion, in-stent stenosis, modified Rankin Scale scores, and complications were recorded. RESULTS: The primary endpoint of complete aneurysm occlusion at 180 d (73.6%) was previously reported. Aneurysm occlusion for those patients with angiographic follow-up progressively increased over time to 86.8% (79/91), 93.4% (71/76), and 95.2% (60/63) at 1, 3, and 5 yr, respectively. Six aneurysms (5.7%) were retreated. New serious device-related events at 1, 3, and 5 yr were noted in 1% (1/96), 3.5% (3/85), and 0% (0/81) of subjects. There were 4 (3.7%) reported deaths in our trial. Seventy-eight (96.3%) of 81 patients with 5-yr clinical follow-up had modified Rankin Scale scores ≤2. No delayed neurological deaths or hemorrhagic or ischemic cerebrovascular events were reported beyond 6 mo. No recanalization of a previously occluded aneurysm was observed. CONCLUSION: Our 5-yr findings demonstrate that PED is a safe and effective treatment for large and giant wide-necked aneurysms of the intracranial ICA, with high rates of complete occlusion and low rates of delayed adverse events.
引用
- Becske T, Brinjikji W, Potts MB, et al. Long-Term Clinical and Angiographic Outcomes Following Pipeline Embolization Device Treatment of Complex Internal Carotid Artery Aneurysms: Five-Year Results of the Pipeline for Uncoilable or Failed Aneurysms Trial. Neurosurgery. 2017. PMID: 28362885. doi:10.1093/neuros/nyw014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。